Pharma & Biotech

Intellia Therapeutics shares are experiencing a dramatic downturn after a patient death in a pivotal clinical study triggered multiple analyst...

The acquisition drama surrounding German biopharmaceutical firm CureVac approaches its climax as investors prepare for a landmark shareholder vote. With...

Danish pharmaceutical giant Novo Nordisk finds itself navigating turbulent waters following a series of damaging developments. Investors are growing increasingly...

Alphabet Inc., the parent company of Google, encountered significant headwinds on Thursday as two separate challenges emerged simultaneously. The technology...

The healthcare conglomerate Johnson & Johnson is demonstrating remarkable resilience in volatile market conditions, propelled by an outstanding earnings report...

A patient death during a critical Phase 3 study has triggered a severe downturn for gene-editing company Intellia Therapeutics. The...

CytomX Therapeutics finds itself at a critical juncture, presenting investors with a complex picture of near-term financial pressures against a...

The biotechnology sector is watching closely as Kura Oncology approaches a defining moment in its corporate history. The company's future...

Eli Lilly and Company has achieved a historic market milestone, with its share price closing above the $1,000 threshold for...

Pharmaceutical giant AbbVie is demonstrating strategic agility as it shifts resources toward promising growth areas while exiting less productive ventures....